

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.58539878 |
| 2 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.52136517 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.14952634 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.14952634 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.96316532 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.94138111 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.94138111 |
| 8 | axonemal dynein complex assembly (GO:0070286) | 4.93610435 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.87539010 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.87539010 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.87539010 |
| 12 | cilium movement (GO:0003341) | 4.82237886 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.73178891 |
| 14 | tryptophan metabolic process (GO:0006568) | 4.72232347 |
| 15 | cysteine metabolic process (GO:0006534) | 4.70243363 |
| 16 | urea metabolic process (GO:0019627) | 4.66195763 |
| 17 | urea cycle (GO:0000050) | 4.66195763 |
| 18 | epithelial cilium movement (GO:0003351) | 4.64659250 |
| 19 | homocysteine metabolic process (GO:0050667) | 4.58746921 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.53967435 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.45900000 |
| 22 | axoneme assembly (GO:0035082) | 4.42428804 |
| 23 | bile acid and bile salt transport (GO:0015721) | 4.27526412 |
| 24 | lysine catabolic process (GO:0006554) | 4.23892805 |
| 25 | lysine metabolic process (GO:0006553) | 4.23892805 |
| 26 | bile acid biosynthetic process (GO:0006699) | 4.22368773 |
| 27 | fucose catabolic process (GO:0019317) | 4.22095459 |
| 28 | L-fucose metabolic process (GO:0042354) | 4.22095459 |
| 29 | L-fucose catabolic process (GO:0042355) | 4.22095459 |
| 30 | cellular glucuronidation (GO:0052695) | 4.18509452 |
| 31 | glyoxylate metabolic process (GO:0046487) | 4.16983143 |
| 32 | negative regulation of sterol transport (GO:0032372) | 4.15694410 |
| 33 | negative regulation of cholesterol transport (GO:0032375) | 4.15694410 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 4.14034080 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.12891164 |
| 36 | high-density lipoprotein particle remodeling (GO:0034375) | 4.09143168 |
| 37 | alpha-linolenic acid metabolic process (GO:0036109) | 4.07995535 |
| 38 | drug transmembrane transport (GO:0006855) | 4.04419145 |
| 39 | protein carboxylation (GO:0018214) | 4.04159061 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.04159061 |
| 41 | bile acid metabolic process (GO:0008206) | 4.04002064 |
| 42 | drug catabolic process (GO:0042737) | 4.02178172 |
| 43 | behavioral response to nicotine (GO:0035095) | 4.00627018 |
| 44 | intestinal cholesterol absorption (GO:0030299) | 3.92459204 |
| 45 | serine family amino acid catabolic process (GO:0009071) | 3.86753901 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 3.86269769 |
| 47 | intestinal absorption (GO:0050892) | 3.81583950 |
| 48 | reverse cholesterol transport (GO:0043691) | 3.81244926 |
| 49 | complement activation, alternative pathway (GO:0006957) | 3.80702478 |
| 50 | sulfation (GO:0051923) | 3.77822564 |
| 51 | urate metabolic process (GO:0046415) | 3.75031077 |
| 52 | regulation of protein activation cascade (GO:2000257) | 3.73719120 |
| 53 | uronic acid metabolic process (GO:0006063) | 3.73048345 |
| 54 | glucuronate metabolic process (GO:0019585) | 3.73048345 |
| 55 | kidney morphogenesis (GO:0060993) | 3.72953053 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 3.68455131 |
| 57 | protein-lipid complex remodeling (GO:0034368) | 3.66107653 |
| 58 | macromolecular complex remodeling (GO:0034367) | 3.66107653 |
| 59 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66107653 |
| 60 | phospholipid efflux (GO:0033700) | 3.65617473 |
| 61 | valine metabolic process (GO:0006573) | 3.65124250 |
| 62 | aromatic amino acid family metabolic process (GO:0009072) | 3.63947170 |
| 63 | drug transport (GO:0015893) | 3.57007014 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 3.54410201 |
| 65 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.53198520 |
| 66 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.53198520 |
| 67 | regulation of complement activation (GO:0030449) | 3.53069338 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 3.49031354 |
| 69 | sulfate transmembrane transport (GO:1902358) | 3.48914846 |
| 70 | response to nitrosative stress (GO:0051409) | 3.46374261 |
| 71 | flavonoid metabolic process (GO:0009812) | 3.46060320 |
| 72 | phospholipid homeostasis (GO:0055091) | 3.45695689 |
| 73 | regulation of bile acid biosynthetic process (GO:0070857) | 3.45681786 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 3.43849384 |
| 75 | neural tube formation (GO:0001841) | 3.43056247 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 3.40087520 |
| 77 | acylglycerol homeostasis (GO:0055090) | 3.39412950 |
| 78 | triglyceride homeostasis (GO:0070328) | 3.39412950 |
| 79 | negative regulation of fibrinolysis (GO:0051918) | 3.37971261 |
| 80 | oxidative demethylation (GO:0070989) | 3.37369504 |
| 81 | exogenous drug catabolic process (GO:0042738) | 3.36834520 |
| 82 | regulation of hippo signaling (GO:0035330) | 3.35733735 |
| 83 | regulation of cholesterol homeostasis (GO:2000188) | 3.32869074 |
| 84 | cholesterol efflux (GO:0033344) | 3.32778107 |
| 85 | alpha-amino acid catabolic process (GO:1901606) | 3.31738515 |
| 86 | motile cilium assembly (GO:0044458) | 3.30647253 |
| 87 | tyrosine metabolic process (GO:0006570) | 3.30005227 |
| 88 | thyroid hormone metabolic process (GO:0042403) | 3.29849171 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 3.29479208 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 3.29271027 |
| 91 | regulation of fibrinolysis (GO:0051917) | 3.28810509 |
| 92 | lipoprotein metabolic process (GO:0042157) | 3.26577982 |
| 93 | ethanol oxidation (GO:0006069) | 3.24708151 |
| 94 | cellular biogenic amine catabolic process (GO:0042402) | 3.22896347 |
| 95 | amine catabolic process (GO:0009310) | 3.22896347 |
| 96 | sterol homeostasis (GO:0055092) | 3.21299051 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.19339490 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.17874054 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 3.15533509 |
| 100 | plasma lipoprotein particle clearance (GO:0034381) | 3.15227371 |
| 101 | glycine metabolic process (GO:0006544) | 3.14877465 |
| 102 | rRNA catabolic process (GO:0016075) | 3.13559265 |
| 103 | protein-lipid complex assembly (GO:0065005) | 3.11446047 |
| 104 | intestinal epithelial cell development (GO:0060576) | 3.08803766 |
| 105 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.05938899 |
| 106 | serine family amino acid biosynthetic process (GO:0009070) | 3.05684390 |
| 107 | plasma lipoprotein particle organization (GO:0071827) | 3.05065142 |
| 108 | short-chain fatty acid metabolic process (GO:0046459) | 3.04748225 |
| 109 | xenobiotic catabolic process (GO:0042178) | 3.03134659 |
| 110 | photoreceptor cell maintenance (GO:0045494) | 3.01436550 |
| 111 | * UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.01388301 |
| 112 | fatty acid oxidation (GO:0019395) | 3.00449888 |
| 113 | sulfate transport (GO:0008272) | 2.98893816 |
| 114 | epoxygenase P450 pathway (GO:0019373) | 2.98773758 |
| 115 | low-density lipoprotein particle remodeling (GO:0034374) | 2.98424228 |
| 116 | hormone catabolic process (GO:0042447) | 2.98393163 |
| 117 | positive regulation of fatty acid oxidation (GO:0046321) | 2.96801473 |
| 118 | carnitine metabolic process (GO:0009437) | 2.96471308 |
| 119 | lipid oxidation (GO:0034440) | 2.95921609 |
| 120 | cilium organization (GO:0044782) | 2.95167821 |
| 121 | drug metabolic process (GO:0017144) | 2.93749780 |
| 122 | ketone body metabolic process (GO:1902224) | 2.93351095 |
| 123 | positive regulation of lipid catabolic process (GO:0050996) | 2.93070801 |
| 124 | glutamate metabolic process (GO:0006536) | 2.92210293 |
| 125 | protein-lipid complex subunit organization (GO:0071825) | 2.90694118 |
| 126 | regulation of mesoderm development (GO:2000380) | 2.90688375 |
| 127 | coenzyme catabolic process (GO:0009109) | 2.88927372 |
| 128 | fatty acid beta-oxidation (GO:0006635) | 2.88699834 |
| 129 | cellular ketone body metabolic process (GO:0046950) | 2.87542042 |
| 130 | regulation of guanylate cyclase activity (GO:0031282) | 2.86804330 |
| 131 | cilium assembly (GO:0042384) | 2.85584177 |
| 132 | 2-oxoglutarate metabolic process (GO:0006103) | 2.85334768 |
| 133 | somite rostral/caudal axis specification (GO:0032525) | 2.85036683 |
| 134 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.81773609 |
| 135 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.80449848 |
| 136 | detection of light stimulus involved in visual perception (GO:0050908) | 2.80449848 |
| 137 | fucosylation (GO:0036065) | 2.78617591 |
| 138 | regulation of pigment cell differentiation (GO:0050932) | 2.77842828 |
| 139 | vitamin transmembrane transport (GO:0035461) | 2.77545772 |
| 140 | reflex (GO:0060004) | 2.75581374 |
| 141 | alkaloid metabolic process (GO:0009820) | 2.73339843 |
| 142 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.72202548 |
| 143 | cilium morphogenesis (GO:0060271) | 2.71597366 |
| 144 | transepithelial transport (GO:0070633) | 2.69549455 |
| 145 | indole-containing compound metabolic process (GO:0042430) | 2.68280376 |
| 146 | negative regulation of sodium ion transport (GO:0010766) | 2.64472758 |
| 147 | oligosaccharide biosynthetic process (GO:0009312) | 2.63798347 |
| 148 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.63576634 |
| 149 | cornea development in camera-type eye (GO:0061303) | 2.63569037 |
| 150 | interkinetic nuclear migration (GO:0022027) | 2.61550531 |
| 151 | response to pheromone (GO:0019236) | 2.61157193 |
| 152 | behavioral response to ethanol (GO:0048149) | 2.59349672 |
| 153 | regulation of cilium movement (GO:0003352) | 2.56084837 |
| 154 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.55560977 |
| 155 | somite development (GO:0061053) | 2.54192635 |
| 156 | endoderm formation (GO:0001706) | 2.53882960 |
| 157 | establishment of protein localization to Golgi (GO:0072600) | 2.52965153 |
| 158 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.49404181 |
| 159 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.49078959 |
| 160 | lipid translocation (GO:0034204) | 2.48831480 |
| 161 | phospholipid translocation (GO:0045332) | 2.48831480 |
| 162 | arginine metabolic process (GO:0006525) | 2.48805702 |
| 163 | bicarbonate transport (GO:0015701) | 2.48550942 |
| 164 | digestion (GO:0007586) | 2.46349584 |
| 165 | primary alcohol catabolic process (GO:0034310) | 2.46014057 |
| 166 | retinoic acid metabolic process (GO:0042573) | 2.43937000 |
| 167 | sulfur compound transport (GO:0072348) | 2.43726091 |
| 168 | thyroid hormone generation (GO:0006590) | 2.43634856 |
| 169 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.43633833 |
| 170 | left/right axis specification (GO:0070986) | 2.43356472 |
| 171 | intraciliary transport (GO:0042073) | 2.42320593 |
| 172 | neuronal action potential (GO:0019228) | 2.40948611 |
| 173 | ethanol metabolic process (GO:0006067) | 2.39060855 |
| 174 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.38118981 |
| 175 | embryonic epithelial tube formation (GO:0001838) | 2.37904079 |
| 176 | cellular response to sterol (GO:0036315) | 2.37316472 |
| 177 | phenol-containing compound catabolic process (GO:0019336) | 2.36764531 |
| 178 | positive regulation of fatty acid transport (GO:2000193) | 2.36482630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.87235702 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.87289133 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.22231061 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.14129519 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.85721244 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.31369158 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.20595120 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.01493057 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.98333395 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.89619038 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.86856399 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.86517923 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.79428945 |
| 14 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.57799171 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.57657769 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.54924523 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.53189718 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.51895129 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42042245 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.34989247 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33879182 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.25608108 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.20742613 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.15397866 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10042468 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08170421 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 2.08020360 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.06678136 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.06591267 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04410211 |
| 31 | EWS_26573619_Chip-Seq_HEK293_Human | 2.04350835 |
| 32 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.03072217 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.01864553 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.99532808 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99506201 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93338135 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.90198479 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.90198031 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86761547 |
| 40 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81178458 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.80715351 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.78067635 |
| 43 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.75661856 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74071977 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.71981660 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.69591806 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69323489 |
| 48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67430304 |
| 49 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65456710 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.64220417 |
| 51 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.62610695 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61896749 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.61446651 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59372887 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58005036 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55400186 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55247643 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55030941 |
| 59 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54502381 |
| 60 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.54411100 |
| 61 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54103132 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.52822694 |
| 63 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.52732463 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50513300 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.50332451 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.50332451 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.48250944 |
| 68 | TCF4_23295773_ChIP-Seq_U87_Human | 1.47547875 |
| 69 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47526858 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47078965 |
| 71 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.46340537 |
| 72 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46234379 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.46119431 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44599665 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44190244 |
| 76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43676606 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42410095 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.41691785 |
| 79 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41549611 |
| 80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39432396 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.38826051 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38155721 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34156739 |
| 84 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.34095268 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33910438 |
| 86 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33799836 |
| 87 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.32462607 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31467742 |
| 89 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30967160 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.28948863 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28097172 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.28089614 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.25219177 |
| 94 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25217942 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24126179 |
| 96 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23734002 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.23670201 |
| 98 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23566203 |
| 99 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23322782 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22806495 |
| 101 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22650033 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.22480181 |
| 103 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.22208205 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.22208205 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20067003 |
| 106 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19887045 |
| 107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19508313 |
| 108 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18615916 |
| 109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17198003 |
| 110 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15312240 |
| 111 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15312240 |
| 112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14133211 |
| 113 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.14122811 |
| 114 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12675199 |
| 115 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12596023 |
| 116 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.12346048 |
| 117 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11969946 |
| 118 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11836863 |
| 119 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11794543 |
| 120 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11368684 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10516287 |
| 122 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09271493 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08833773 |
| 124 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08640506 |
| 125 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08574305 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08085883 |
| 127 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07161730 |
| 128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07161730 |
| 129 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06771796 |
| 130 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05976698 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.05710519 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05696165 |
| 133 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05696165 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04890019 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04397885 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04281294 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04250461 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04250461 |
| 139 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.03044712 |
| 140 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96549045 |
| 141 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95286869 |
| 142 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95192874 |
| 143 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94798422 |
| 144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94506936 |
| 145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94320674 |
| 146 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93809659 |
| 147 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93056265 |
| 148 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92887413 |
| 149 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92520186 |
| 150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91865040 |
| 151 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89686665 |
| 152 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89027041 |
| 153 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85454773 |
| 154 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85219624 |
| 155 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85087913 |
| 156 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84376319 |
| 157 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82589167 |
| 158 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80304694 |
| 159 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80108128 |
| 160 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.78430845 |
| 161 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77158254 |
| 162 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.76879382 |
| 163 | * MYB_26560356_Chip-Seq_TH1_Human | 0.75923745 |
| 164 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.75911757 |
| 165 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75288471 |
| 166 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74668113 |
| 167 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74414416 |
| 168 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73592513 |
| 169 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.73213259 |
| 170 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.71933014 |
| 171 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71522144 |
| 172 | MYB_26560356_Chip-Seq_TH2_Human | 0.69899361 |
| 173 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69352568 |
| 174 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.69092281 |
| 175 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.68860231 |
| 176 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.68305620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.33466777 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.90322390 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.85380077 |
| 4 | MP0005365_abnormal_bile_salt | 4.80297456 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.98183583 |
| 6 | MP0003252_abnormal_bile_duct | 3.63829112 |
| 7 | MP0000569_abnormal_digit_pigmentation | 3.00144485 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.98771557 |
| 9 | MP0003890_abnormal_embryonic-extraembry | 2.92801650 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.88849308 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.65499963 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.41078277 |
| 13 | MP0009840_abnormal_foam_cell | 2.21798543 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.21036611 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.13045251 |
| 16 | MP0005332_abnormal_amino_acid | 2.12369517 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.11103196 |
| 18 | MP0008872_abnormal_physiological_respon | 2.03550112 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.01638834 |
| 20 | MP0003868_abnormal_feces_composition | 1.95714285 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.94275959 |
| 22 | MP0005083_abnormal_biliary_tract | 1.86199703 |
| 23 | MP0003195_calcinosis | 1.83796580 |
| 24 | MP0000609_abnormal_liver_physiology | 1.80569077 |
| 25 | MP0001485_abnormal_pinna_reflex | 1.79158370 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 1.75163987 |
| 27 | MP0001664_abnormal_digestion | 1.73972258 |
| 28 | MP0004133_heterotaxia | 1.64047141 |
| 29 | MP0002160_abnormal_reproductive_system | 1.60418933 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.58733877 |
| 31 | MP0001873_stomach_inflammation | 1.54292004 |
| 32 | MP0003283_abnormal_digestive_organ | 1.52676608 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.51634086 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.49936153 |
| 35 | MP0002102_abnormal_ear_morphology | 1.49829208 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.48435589 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.48130773 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.46855105 |
| 39 | MP0003119_abnormal_digestive_system | 1.37564054 |
| 40 | MP0009764_decreased_sensitivity_to | 1.37348749 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.35814426 |
| 42 | MP0003646_muscle_fatigue | 1.34700767 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.32119653 |
| 44 | MP0005389_reproductive_system_phenotype | 1.31383354 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.30857403 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.30344583 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.28695005 |
| 48 | MP0000631_abnormal_neuroendocrine_gland | 1.28232640 |
| 49 | MP0006292_abnormal_olfactory_placode | 1.24888973 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.24635063 |
| 51 | MP0001764_abnormal_homeostasis | 1.24253827 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.21579405 |
| 53 | MP0008877_abnormal_DNA_methylation | 1.20652922 |
| 54 | MP0005636_abnormal_mineral_homeostasis | 1.17389094 |
| 55 | MP0009697_abnormal_copulation | 1.17007521 |
| 56 | MP0002653_abnormal_ependyma_morphology | 1.16198958 |
| 57 | MP0003436_decreased_susceptibility_to | 1.14843796 |
| 58 | MP0002938_white_spotting | 1.14706531 |
| 59 | MP0003937_abnormal_limbs/digits/tail_de | 1.13714446 |
| 60 | MP0009046_muscle_twitch | 1.11524752 |
| 61 | MP0000230_abnormal_systemic_arterial | 1.11425885 |
| 62 | MP0003186_abnormal_redox_activity | 1.10913158 |
| 63 | MP0004142_abnormal_muscle_tone | 1.10887153 |
| 64 | MP0001968_abnormal_touch/_nociception | 1.09805668 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.09222650 |
| 66 | MP0002736_abnormal_nociception_after | 1.07359551 |
| 67 | MP0008469_abnormal_protein_level | 1.07234041 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.05887611 |
| 69 | MP0005408_hypopigmentation | 1.05795071 |
| 70 | MP0005647_abnormal_sex_gland | 1.05081278 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 1.04989847 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 1.04053423 |
| 73 | MP0005253_abnormal_eye_physiology | 1.03663073 |
| 74 | MP0004043_abnormal_pH_regulation | 1.03282908 |
| 75 | MP0003718_maternal_effect | 1.03162377 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.02830899 |
| 77 | MP0002136_abnormal_kidney_physiology | 1.01853374 |
| 78 | MP0004924_abnormal_behavior | 1.00878913 |
| 79 | MP0005386_behavior/neurological_phenoty | 1.00878913 |
| 80 | MP0003724_increased_susceptibility_to | 1.00539322 |
| 81 | MP0001756_abnormal_urination | 0.99237540 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98800862 |
| 83 | MP0002234_abnormal_pharynx_morphology | 0.98796975 |
| 84 | MP0000598_abnormal_liver_morphology | 0.98230578 |
| 85 | MP0000470_abnormal_stomach_morphology | 0.97630016 |
| 86 | MP0000013_abnormal_adipose_tissue | 0.96991830 |
| 87 | MP0001919_abnormal_reproductive_system | 0.95835150 |
| 88 | MP0010386_abnormal_urinary_bladder | 0.95609238 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.95137741 |
| 90 | MP0002254_reproductive_system_inflammat | 0.94904208 |
| 91 | MP0004947_skin_inflammation | 0.94473005 |
| 92 | MP0009384_cardiac_valve_regurgitation | 0.93693328 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.92642876 |
| 94 | MP0002006_tumorigenesis | 0.92347376 |
| 95 | MP0001835_abnormal_antigen_presentation | 0.91043592 |
| 96 | MP0002557_abnormal_social/conspecific_i | 0.90141174 |
| 97 | MP0005448_abnormal_energy_balance | 0.89528642 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.89176665 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 0.88616956 |
| 100 | MP0009763_increased_sensitivity_to | 0.88357886 |
| 101 | MP0004885_abnormal_endolymph | 0.88096613 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.87963264 |
| 103 | MP0002272_abnormal_nervous_system | 0.87782794 |
| 104 | MP0001663_abnormal_digestive_system | 0.87746594 |
| 105 | MP0005451_abnormal_body_composition | 0.87415215 |
| 106 | MP0005195_abnormal_posterior_eye | 0.86025937 |
| 107 | MP0001984_abnormal_olfaction | 0.85457948 |
| 108 | MP0003866_abnormal_defecation | 0.84991537 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.84375543 |
| 110 | MP0003453_abnormal_keratinocyte_physiol | 0.84211757 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.84140582 |
| 112 | MP0009785_altered_susceptibility_to | 0.83734133 |
| 113 | MP0006054_spinal_hemorrhage | 0.83477106 |
| 114 | MP0001188_hyperpigmentation | 0.82297270 |
| 115 | MP0009745_abnormal_behavioral_response | 0.81890229 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.81345282 |
| 117 | MP0008057_abnormal_DNA_replication | 0.79820154 |
| 118 | MP0002419_abnormal_innate_immunity | 0.79001799 |
| 119 | MP0008004_abnormal_stomach_pH | 0.78632050 |
| 120 | MP0002735_abnormal_chemical_nociception | 0.78428935 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.78407996 |
| 122 | MP0004147_increased_porphyrin_level | 0.78129805 |
| 123 | MP0000490_abnormal_crypts_of | 0.77114015 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.77000346 |
| 125 | MP0005187_abnormal_penis_morphology | 0.76694416 |
| 126 | MP0002928_abnormal_bile_duct | 0.75966318 |
| 127 | MP0001881_abnormal_mammary_gland | 0.75896364 |
| 128 | MP0000647_abnormal_sebaceous_gland | 0.75686004 |
| 129 | MP0003183_abnormal_peptide_metabolism | 0.75183498 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.74944757 |
| 131 | MP0000538_abnormal_urinary_bladder | 0.74744308 |
| 132 | MP0003136_yellow_coat_color | 0.74111964 |
| 133 | MP0002009_preneoplasia | 0.73985827 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.73544774 |
| 135 | MP0000477_abnormal_intestine_morphology | 0.72628519 |
| 136 | MP0005025_abnormal_response_to | 0.72503831 |
| 137 | MP0003936_abnormal_reproductive_system | 0.71475457 |
| 138 | MP0005310_abnormal_salivary_gland | 0.71474297 |
| 139 | MP0002876_abnormal_thyroid_physiology | 0.71107702 |
| 140 | MP0004145_abnormal_muscle_electrophysio | 0.70813728 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.70369058 |
| 142 | MP0005381_digestive/alimentary_phenotyp | 0.69500244 |
| 143 | MP0002098_abnormal_vibrissa_morphology | 0.68597783 |
| 144 | MP0000465_gastrointestinal_hemorrhage | 0.68506910 |
| 145 | MP0005166_decreased_susceptibility_to | 0.68348205 |
| 146 | MP0002060_abnormal_skin_morphology | 0.67992150 |
| 147 | MP0000566_synostosis | 0.67741484 |
| 148 | MP0008995_early_reproductive_senescence | 0.67417248 |
| 149 | MP0003953_abnormal_hormone_level | 0.66876159 |
| 150 | MP0009379_abnormal_foot_pigmentation | 0.66456964 |
| 151 | MP0000377_abnormal_hair_follicle | 0.64006451 |
| 152 | MP0006082_CNS_inflammation | 0.61859412 |
| 153 | MP0001533_abnormal_skeleton_physiology | 0.61434262 |
| 154 | MP0000383_abnormal_hair_follicle | 0.59690033 |
| 155 | MP0000427_abnormal_hair_cycle | 0.58394485 |
| 156 | MP0005334_abnormal_fat_pad | 0.57601987 |
| 157 | MP0001216_abnormal_epidermal_layer | 0.57391601 |
| 158 | MP0005023_abnormal_wound_healing | 0.55502610 |
| 159 | MP0001853_heart_inflammation | 0.55312874 |
| 160 | MP0001800_abnormal_humoral_immune | 0.55210363 |
| 161 | MP0002132_abnormal_respiratory_system | 0.54992567 |
| 162 | MP0005376_homeostasis/metabolism_phenot | 0.52610699 |
| 163 | MP0009053_abnormal_anal_canal | 0.52564871 |
| 164 | MP0000627_abnormal_mammary_gland | 0.52072809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.73393709 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.05089616 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.65874491 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.61422647 |
| 5 | Absent/shortened dynein arms (HP:0200106) | 4.58838770 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.58838770 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.58504713 |
| 8 | Pancreatic cysts (HP:0001737) | 4.53686435 |
| 9 | Xanthomatosis (HP:0000991) | 4.52762634 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.44908329 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.31310274 |
| 12 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.27347886 |
| 13 | Abnormal ciliary motility (HP:0012262) | 4.15450457 |
| 14 | Pancreatic fibrosis (HP:0100732) | 4.10412301 |
| 15 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.10013522 |
| 16 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.08473095 |
| 17 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.08473095 |
| 18 | Conjugated hyperbilirubinemia (HP:0002908) | 4.05896100 |
| 19 | Fat malabsorption (HP:0002630) | 4.05265676 |
| 20 | True hermaphroditism (HP:0010459) | 3.78566919 |
| 21 | Decreased circulating renin level (HP:0003351) | 3.76682469 |
| 22 | Rhinitis (HP:0012384) | 3.66796995 |
| 23 | Complement deficiency (HP:0004431) | 3.64020446 |
| 24 | Molar tooth sign on MRI (HP:0002419) | 3.59284046 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 3.59284046 |
| 26 | Epidermoid cyst (HP:0200040) | 3.58170562 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.56247887 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.51971828 |
| 29 | Joint hemorrhage (HP:0005261) | 3.50246858 |
| 30 | Hyperglycinuria (HP:0003108) | 3.50178384 |
| 31 | Abnormality of the renal cortex (HP:0011035) | 3.45962579 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.42093976 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.39020903 |
| 34 | Hyperammonemia (HP:0001987) | 3.32488289 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.30391973 |
| 36 | Genetic anticipation (HP:0003743) | 3.21661898 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.19913291 |
| 38 | Nephronophthisis (HP:0000090) | 3.19738856 |
| 39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18391172 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 3.18391172 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 3.16140064 |
| 42 | Hyperglycinemia (HP:0002154) | 3.12104452 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.09239921 |
| 44 | Myocardial infarction (HP:0001658) | 3.08851137 |
| 45 | Cystic liver disease (HP:0006706) | 3.05912868 |
| 46 | Acanthocytosis (HP:0001927) | 3.04888945 |
| 47 | Hyperventilation (HP:0002883) | 3.03641364 |
| 48 | Hydroxyprolinuria (HP:0003080) | 3.01952484 |
| 49 | Abnormality of proline metabolism (HP:0010907) | 3.01952484 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 3.01049493 |
| 51 | Abnormality of the renal medulla (HP:0100957) | 3.00100843 |
| 52 | Ketosis (HP:0001946) | 2.98444021 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98045884 |
| 54 | Chronic bronchitis (HP:0004469) | 2.97452564 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.96032814 |
| 56 | Esophageal varix (HP:0002040) | 2.93954683 |
| 57 | Tubular atrophy (HP:0000092) | 2.93926801 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.92038666 |
| 59 | Hypoalphalipoproteinemia (HP:0003233) | 2.91199901 |
| 60 | Vascular calcification (HP:0004934) | 2.90481659 |
| 61 | Steatorrhea (HP:0002570) | 2.89861798 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.86980322 |
| 63 | Chronic hepatic failure (HP:0100626) | 2.79986955 |
| 64 | Abnormality of renin-angiotensin system (HP:0000847) | 2.78576556 |
| 65 | Bronchiectasis (HP:0002110) | 2.78411700 |
| 66 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77602128 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 2.74175582 |
| 68 | Abnormality of complement system (HP:0005339) | 2.74137311 |
| 69 | Abnormality of methionine metabolism (HP:0010901) | 2.70909086 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 2.68016758 |
| 71 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.67311853 |
| 72 | Abnormality of alanine metabolism (HP:0010916) | 2.67311853 |
| 73 | Hyperalaninemia (HP:0003348) | 2.67311853 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.60947120 |
| 75 | Metabolic alkalosis (HP:0200114) | 2.60409480 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.48545047 |
| 77 | Abnormality of the nasal septum (HP:0000419) | 2.48195106 |
| 78 | Protruding tongue (HP:0010808) | 2.48179066 |
| 79 | Hyperbilirubinemia (HP:0002904) | 2.46740784 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.46610220 |
| 81 | Chronic diarrhea (HP:0002028) | 2.46430907 |
| 82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.44561022 |
| 83 | Congenital sensorineural hearing impairment (HP:0008527) | 2.43826126 |
| 84 | Furrowed tongue (HP:0000221) | 2.43006981 |
| 85 | Progressive cerebellar ataxia (HP:0002073) | 2.42652982 |
| 86 | Gout (HP:0001997) | 2.40207233 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38117314 |
| 88 | Abolished electroretinogram (ERG) (HP:0000550) | 2.37998650 |
| 89 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.35996541 |
| 90 | Proximal tubulopathy (HP:0000114) | 2.34717292 |
| 91 | Gingival bleeding (HP:0000225) | 2.32985479 |
| 92 | Hyperactive renin-angiotensin system (HP:0000841) | 2.31013407 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 2.30579380 |
| 94 | Type II lissencephaly (HP:0007260) | 2.30288519 |
| 95 | Fair hair (HP:0002286) | 2.29927941 |
| 96 | Spastic diplegia (HP:0001264) | 2.29673861 |
| 97 | Ketoacidosis (HP:0001993) | 2.28946999 |
| 98 | Malnutrition (HP:0004395) | 2.28621796 |
| 99 | Renal cortical cysts (HP:0000803) | 2.28023552 |
| 100 | Abnormal tarsal ossification (HP:0008369) | 2.25674065 |
| 101 | Attenuation of retinal blood vessels (HP:0007843) | 2.22094935 |
| 102 | Menorrhagia (HP:0000132) | 2.21356461 |
| 103 | Glomerulonephritis (HP:0000099) | 2.20446801 |
| 104 | Metabolic acidosis (HP:0001942) | 2.20169427 |
| 105 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.20116731 |
| 106 | Pancreatitis (HP:0001733) | 2.19895913 |
| 107 | Cerebellar dysplasia (HP:0007033) | 2.19875966 |
| 108 | Bile duct proliferation (HP:0001408) | 2.19799647 |
| 109 | Abnormal biliary tract physiology (HP:0012439) | 2.19799647 |
| 110 | Generalized aminoaciduria (HP:0002909) | 2.19792339 |
| 111 | Congenital, generalized hypertrichosis (HP:0004540) | 2.19591219 |
| 112 | Congenital hepatic fibrosis (HP:0002612) | 2.18211598 |
| 113 | Inability to walk (HP:0002540) | 2.17937017 |
| 114 | Polydipsia (HP:0001959) | 2.16797030 |
| 115 | Abnormal drinking behavior (HP:0030082) | 2.16797030 |
| 116 | Right ventricular cardiomyopathy (HP:0011663) | 2.14222880 |
| 117 | Abdominal distention (HP:0003270) | 2.14126048 |
| 118 | Abnormal foot bone ossification (HP:0010675) | 2.13477303 |
| 119 | Abnormality of serum amino acid levels (HP:0003112) | 2.11995867 |
| 120 | Alkalosis (HP:0001948) | 2.11483716 |
| 121 | Progressive inability to walk (HP:0002505) | 2.11249738 |
| 122 | Vacuolated lymphocytes (HP:0001922) | 2.10489004 |
| 123 | Hypoplastic labia majora (HP:0000059) | 2.09649223 |
| 124 | Anencephaly (HP:0002323) | 2.07005537 |
| 125 | Gait imbalance (HP:0002141) | 2.06792293 |
| 126 | Spontaneous abortion (HP:0005268) | 2.04910663 |
| 127 | Congenital primary aphakia (HP:0007707) | 2.04233413 |
| 128 | Chorioretinal atrophy (HP:0000533) | 2.02215633 |
| 129 | Sensorimotor neuropathy (HP:0007141) | 2.01200735 |
| 130 | Hyperaldosteronism (HP:0000859) | 2.00171460 |
| 131 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99913251 |
| 132 | Abnormality of vitamin B metabolism (HP:0004340) | 1.99662399 |
| 133 | Thrombophlebitis (HP:0004418) | 1.99390263 |
| 134 | Abnormality of chloride homeostasis (HP:0011422) | 1.98974599 |
| 135 | Decreased central vision (HP:0007663) | 1.98686500 |
| 136 | Stomach cancer (HP:0012126) | 1.98378682 |
| 137 | Delayed CNS myelination (HP:0002188) | 1.98146907 |
| 138 | Male pseudohermaphroditism (HP:0000037) | 1.97935422 |
| 139 | Postaxial foot polydactyly (HP:0001830) | 1.97268914 |
| 140 | Hypothermia (HP:0002045) | 1.97175484 |
| 141 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.96748003 |
| 142 | Ileus (HP:0002595) | 1.96373758 |
| 143 | Symptomatic seizures (HP:0011145) | 1.96136491 |
| 144 | Sclerocornea (HP:0000647) | 1.95881380 |
| 145 | Nephritis (HP:0000123) | 1.95665171 |
| 146 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.95622691 |
| 147 | Abnormality of the renal collecting system (HP:0004742) | 1.95230968 |
| 148 | Pendular nystagmus (HP:0012043) | 1.93586015 |
| 149 | Large for gestational age (HP:0001520) | 1.93220065 |
| 150 | Increased purine levels (HP:0004368) | 1.92652289 |
| 151 | Hyperuricemia (HP:0002149) | 1.92652289 |
| 152 | Dicarboxylic aciduria (HP:0003215) | 1.92360091 |
| 153 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92360091 |
| 154 | Abnormality of the labia majora (HP:0012881) | 1.92273918 |
| 155 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.91371700 |
| 156 | Clumsiness (HP:0002312) | 1.89153929 |
| 157 | Increased corneal curvature (HP:0100692) | 1.88953295 |
| 158 | Keratoconus (HP:0000563) | 1.88953295 |
| 159 | Poikilocytosis (HP:0004447) | 1.87098354 |
| 160 | Reduced antithrombin III activity (HP:0001976) | 1.86870172 |
| 161 | Abnormal biliary tract morphology (HP:0012440) | 1.86089888 |
| 162 | Increased mean platelet volume (HP:0011877) | 1.85857778 |
| 163 | Hemorrhage of the eye (HP:0011885) | 1.85269788 |
| 164 | Elevated alkaline phosphatase (HP:0003155) | 1.84053410 |
| 165 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83664223 |
| 166 | Skin nodule (HP:0200036) | 1.83426705 |
| 167 | Genital tract atresia (HP:0001827) | 1.82871353 |
| 168 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.82822299 |
| 169 | Rickets (HP:0002748) | 1.81664852 |
| 170 | Generalized hypopigmentation of hair (HP:0011358) | 1.81524537 |
| 171 | Glycosuria (HP:0003076) | 1.81148582 |
| 172 | Abnormality of urine glucose concentration (HP:0011016) | 1.81148582 |
| 173 | Abnormal platelet function (HP:0011869) | 1.80812106 |
| 174 | Impaired platelet aggregation (HP:0003540) | 1.80812106 |
| 175 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80669369 |
| 176 | Broad-based gait (HP:0002136) | 1.80142209 |
| 177 | Pigmentary retinal degeneration (HP:0001146) | 1.78643898 |
| 178 | Mitral stenosis (HP:0001718) | 1.78137078 |
| 179 | Confusion (HP:0001289) | 1.78129194 |
| 180 | Vaginal atresia (HP:0000148) | 1.77410007 |
| 181 | Periodontitis (HP:0000704) | 1.76422631 |
| 182 | Hypochromic microcytic anemia (HP:0004840) | 1.76247682 |
| 183 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.75272219 |
| 184 | Duplicated collecting system (HP:0000081) | 1.72166661 |
| 185 | Asplenia (HP:0001746) | 1.68399407 |
| 186 | Hyperkalemia (HP:0002153) | 1.64539467 |
| 187 | Patellar aplasia (HP:0006443) | 1.63714818 |
| 188 | Abnormality of potassium homeostasis (HP:0011042) | 1.63066844 |
| 189 | Short hallux (HP:0010109) | 1.61942544 |
| 190 | Bronchitis (HP:0012387) | 1.61446544 |
| 191 | Hypokalemia (HP:0002900) | 1.61228372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 5.29396896 |
| 2 | FRK | 5.15627347 |
| 3 | BMPR1B | 3.43327389 |
| 4 | SIK1 | 2.99244849 |
| 5 | MST1R | 2.90781544 |
| 6 | ERN1 | 2.68664581 |
| 7 | LATS1 | 2.67042728 |
| 8 | TAOK3 | 2.65481049 |
| 9 | ADRBK2 | 2.51676507 |
| 10 | BCKDK | 2.39899230 |
| 11 | INSRR | 2.30951927 |
| 12 | FGFR4 | 2.17989062 |
| 13 | MST4 | 2.17544208 |
| 14 | MAP3K14 | 2.14149209 |
| 15 | NUAK1 | 1.87608068 |
| 16 | TLK1 | 1.87586240 |
| 17 | TYK2 | 1.83426690 |
| 18 | MAP4K2 | 1.81844625 |
| 19 | PINK1 | 1.77243018 |
| 20 | FLT3 | 1.64942382 |
| 21 | MAPK13 | 1.62730284 |
| 22 | PTK6 | 1.62452075 |
| 23 | FGFR3 | 1.59170876 |
| 24 | CASK | 1.57796282 |
| 25 | MAP3K4 | 1.54704000 |
| 26 | CAMK1D | 1.54562162 |
| 27 | NEK9 | 1.50718457 |
| 28 | EPHA2 | 1.45701685 |
| 29 | JAK1 | 1.43358506 |
| 30 | JAK3 | 1.38438475 |
| 31 | RIPK1 | 1.37566124 |
| 32 | STK3 | 1.34468139 |
| 33 | LMTK2 | 1.33530762 |
| 34 | TGFBR2 | 1.32422719 |
| 35 | TNIK | 1.31364043 |
| 36 | IRAK3 | 1.30088804 |
| 37 | STK10 | 1.29887259 |
| 38 | MAPK11 | 1.29679207 |
| 39 | ERBB4 | 1.29280460 |
| 40 | TGFBR1 | 1.24197706 |
| 41 | PKN2 | 1.23432277 |
| 42 | CDK6 | 1.22583033 |
| 43 | TBK1 | 1.22198306 |
| 44 | ERBB3 | 1.22088893 |
| 45 | SCYL2 | 1.20085766 |
| 46 | PRKAA2 | 1.19974254 |
| 47 | MAP3K3 | 1.16018629 |
| 48 | ADRBK1 | 1.14026640 |
| 49 | EEF2K | 1.13221851 |
| 50 | DAPK2 | 1.11453097 |
| 51 | MKNK2 | 1.04190710 |
| 52 | MAP3K7 | 0.99520206 |
| 53 | PIK3CA | 0.99214587 |
| 54 | JAK2 | 0.95934582 |
| 55 | PIK3CG | 0.92971076 |
| 56 | PRKG2 | 0.92659078 |
| 57 | MET | 0.92501251 |
| 58 | IKBKE | 0.91245838 |
| 59 | MAP3K2 | 0.89966434 |
| 60 | MAPKAPK3 | 0.89571458 |
| 61 | STK24 | 0.89275856 |
| 62 | TEC | 0.88429179 |
| 63 | MAP2K3 | 0.87803523 |
| 64 | AKT3 | 0.87134789 |
| 65 | MAP2K7 | 0.85077767 |
| 66 | FGFR2 | 0.84771853 |
| 67 | ERBB2 | 0.84295423 |
| 68 | NLK | 0.83261864 |
| 69 | MAP2K2 | 0.83021789 |
| 70 | CHUK | 0.82255908 |
| 71 | MAP4K1 | 0.81128953 |
| 72 | EPHA3 | 0.81013684 |
| 73 | BCR | 0.80663370 |
| 74 | PRKCE | 0.80449563 |
| 75 | CSF1R | 0.80323885 |
| 76 | CSK | 0.77648931 |
| 77 | TRPM7 | 0.77321055 |
| 78 | STK39 | 0.76959053 |
| 79 | ITK | 0.76903339 |
| 80 | IRAK4 | 0.76667030 |
| 81 | CAMKK2 | 0.74163559 |
| 82 | ZAK | 0.73196746 |
| 83 | MAP3K10 | 0.72041062 |
| 84 | NEK2 | 0.70045389 |
| 85 | CDK9 | 0.69768950 |
| 86 | MAP2K6 | 0.68427735 |
| 87 | PAK3 | 0.67249657 |
| 88 | STK38L | 0.66409759 |
| 89 | PDK2 | 0.66379205 |
| 90 | WNK1 | 0.66243143 |
| 91 | PBK | 0.66083095 |
| 92 | SGK3 | 0.65924006 |
| 93 | OXSR1 | 0.65205704 |
| 94 | RPS6KA4 | 0.64254969 |
| 95 | PNCK | 0.63659689 |
| 96 | IKBKB | 0.63060330 |
| 97 | GRK6 | 0.63031988 |
| 98 | MAP3K13 | 0.62518606 |
| 99 | KIT | 0.62276604 |
| 100 | LRRK2 | 0.62081243 |
| 101 | MUSK | 0.61361211 |
| 102 | PRKAA1 | 0.60903492 |
| 103 | TRIB3 | 0.60653332 |
| 104 | TXK | 0.60047009 |
| 105 | CAMK1G | 0.59038972 |
| 106 | KDR | 0.58406816 |
| 107 | WNK3 | 0.56990729 |
| 108 | ZAP70 | 0.56256785 |
| 109 | TRIM28 | 0.55724459 |
| 110 | BTK | 0.55323823 |
| 111 | GRK1 | 0.55236529 |
| 112 | EIF2AK3 | 0.53362631 |
| 113 | MAPK15 | 0.52109429 |
| 114 | GSK3A | 0.52001296 |
| 115 | MELK | 0.51320597 |
| 116 | PIM1 | 0.50877383 |
| 117 | CDK8 | 0.50738902 |
| 118 | YES1 | 0.49519589 |
| 119 | SGK2 | 0.49343063 |
| 120 | PRKCQ | 0.46863197 |
| 121 | BLK | 0.46115385 |
| 122 | IGF1R | 0.45425979 |
| 123 | SIK3 | 0.44246919 |
| 124 | FER | 0.44071575 |
| 125 | MATK | 0.43666161 |
| 126 | RPS6KA5 | 0.43005051 |
| 127 | EIF2AK2 | 0.42904141 |
| 128 | WNK4 | 0.42072850 |
| 129 | MAP2K1 | 0.40212013 |
| 130 | MAP3K8 | 0.40121611 |
| 131 | BRSK2 | 0.38894019 |
| 132 | ABL1 | 0.38561650 |
| 133 | IRAK1 | 0.37809338 |
| 134 | PTK2B | 0.37787968 |
| 135 | CAMK2A | 0.37199143 |
| 136 | CSNK1A1 | 0.35994110 |
| 137 | TIE1 | 0.34682773 |
| 138 | PRKACA | 0.34378694 |
| 139 | PRKCA | 0.33950541 |
| 140 | PRKCI | 0.32874951 |
| 141 | PRKCG | 0.32323926 |
| 142 | MKNK1 | 0.31676896 |
| 143 | WEE1 | 0.30774078 |
| 144 | SGK223 | 0.30658128 |
| 145 | SGK494 | 0.30658128 |
| 146 | STK11 | 0.29931606 |
| 147 | SGK1 | 0.28271226 |
| 148 | RPS6KA6 | 0.27901806 |
| 149 | CSNK1A1L | 0.26225261 |
| 150 | NEK6 | 0.26129623 |
| 151 | STK38 | 0.24314510 |
| 152 | PRKCZ | 0.24070424 |
| 153 | CSNK1D | 0.23786332 |
| 154 | PHKG1 | 0.23277118 |
| 155 | PHKG2 | 0.23277118 |
| 156 | MAPKAPK5 | 0.22154198 |
| 157 | CSNK1G1 | 0.21219674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.58126055 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47298347 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02253541 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.80158767 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54957946 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.50422100 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.45803892 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.37788310 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.31790131 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14820349 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11900015 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.06555820 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05965300 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.96065605 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.90585252 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89581213 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.88267293 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84841408 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84227523 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83485001 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.82205564 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.75456192 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74274510 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.73303180 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.71014742 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68875728 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.68858684 |
| 28 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.67293600 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67019322 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63280560 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62354862 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.61513006 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59310720 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.58319133 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54930788 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.52652910 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.50494161 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50104241 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48166445 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.43513126 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41916960 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.40777928 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38600391 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22972653 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.22581319 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18556956 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 1.14693794 |
| 48 | Nicotine addiction_Homo sapiens_hsa05033 | 1.14628341 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11683231 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.09094115 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04949491 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04296396 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.03190728 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01023168 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92553987 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91367811 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88145238 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87253267 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86141425 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83763908 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83482767 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.83312260 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81600939 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80788434 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.80522185 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79820218 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79523727 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 0.79031919 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78919058 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77761905 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76868584 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.75197286 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74157593 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73032017 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69980893 |
| 76 | Salivary secretion_Homo sapiens_hsa04970 | 0.67381859 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.66364507 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65139191 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64832461 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64759269 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63527771 |
| 82 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63247258 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.62853430 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62471337 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59570064 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58296590 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57094635 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56716390 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56490101 |
| 90 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52998427 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.51590916 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50896469 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.49608173 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48349172 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.45281693 |
| 96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44215293 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43822449 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.43346629 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42558073 |
| 100 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41642367 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41074081 |
| 102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39945475 |
| 103 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38824887 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.38473133 |
| 105 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38469363 |
| 106 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.37372913 |
| 107 | Basal transcription factors_Homo sapiens_hsa03022 | 0.36933000 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36221034 |
| 109 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.35820172 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35654207 |
| 111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34376566 |
| 112 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34044518 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33882944 |
| 114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33691222 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.33114322 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32311931 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.32100799 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32066723 |
| 119 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28534879 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27209128 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27054478 |
| 122 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26711721 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23760278 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23555419 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.22612916 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.22013777 |
| 127 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.21597500 |
| 128 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.20442174 |
| 129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.20427175 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19921613 |
| 131 | Protein export_Homo sapiens_hsa03060 | 0.18677179 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.18309229 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.18264978 |
| 134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.18113646 |
| 135 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.17099635 |
| 136 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.16991460 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.16955672 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.16550498 |
| 139 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.16132071 |
| 140 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.10926965 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10890507 |
| 142 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10085591 |

